Search filters

List of works by Maryam Ehteshami

2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture.

scientific article published on 8 June 2017

Approaches to hepatitis C treatment and cure using NS5A inhibitors

scientific article published on 05 March 2014

Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.

scientific article

Characterization of β-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus

scientific article

Chutes and ladders in hepatitis C nucleoside drug development

scientific article

Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus

scientific article published on 07 February 2019

Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitors

scientific article

Metabolism of Nucleosides and Nucleotides Prodrugs

scientific article published on 11 October 2017

Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase

scientific article published on 30 May 2017

Synthesis and Evaluation of 2,6-Modified Purine 2'-C-Methyl Ribonucleosides as Inhibitors of HCV Replication

scientific article published on 23 November 2015

Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities

scientific article

Towards HBV curative therapies

scientific article published in February 2018

β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms

scientific article